FDA Approved: METHYLPHENIDATE HCL — Original Application (Patrin Pharma, Inc.)

View source ↗

Summary

FDA approved Patrin Pharma, Inc.'s original ANDA for methylphenidate hydrochloride (generic) for the treatment of attention-deficit/hyperactivity disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Methylphenidate HCl (Methylphenidate hydrochloride)

Snippet

ORIG AP for METHYLPHENIDATE HCL (METHYLPHENIDATE HCL)